Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.)
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)

HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits and the "cap and trade" system for agriculture.)

S 1733 A bill to created clean energy jobs, promote energy independence, reduce global warming pollution, and transition to a clean energy economy; (All provisions related to agriculture, allowances and offsets.)

HR 4159 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to require local educational agencies and scholls to implement integrated pest management programs to minimize the use of pesticides in schools and to provide parents, guardians, and employees with notice of the use of pesticides in schools, and for other purposes; (Provisions relating to pesticides.)

Appropriations (no bill number) Seeking funding for the FY 2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.)

EPA Regulations (no bill number) Guidance on spray drift; (Provisions in the guidance related to "may cause harm" and changes to FIFRA.)

NPDES permitting issues (no bill number); (Permitting issues concerning agriculture applications.)

Regulatory Biotech Issues (no bill number); (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, in particular APHIS Part 340.)

ESA Issues (no bill number); (NMFS biological opinions -- Discussions on National Marine Fisheries Biological Opinions that were recently released and their potential affects on agriculture.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

HR 2999 Veterinary Public Health Workforce and Education Act;(In support for legislation.)
HR 3519/S1709 Veterinary Services Investment Act; (Support legislation.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Appropriations (no bill numbers) Seeking funding for the FY 2011 appropriations bills; (All provisions related to agriculture research funding, food security issues, and funding of USDA agencies including APHIS and FAS, EPA and pesticide fees)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CAW

16. Specific lobbying issues

S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changeing the definition of U.S. Waters.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CHM

16. Specific lobbying issues

HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism agains chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

S 515 A bill to amend title 35, US Code to provide for patent reform; (Provisions relating to IPP corporate protection; Provisions relating to apportionment of damages.)
HR 1260 Patent Reform Act of 2009; (Provisions relating to apportionment of damages.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

S 1462 American Clean Energy Leadership Act of 2009; (A bill to promote clean energy technology development; (All provisions related to enhanced energy efficiency and clean energy development.)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENV

16. Specific lobbying issues

HR 2454 the American Clean Energy and Security Act of 2009; (A bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions pertaining to the advancement of a Cap and Trade greenhouse gas reducion system and energy efficiency measures.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOO

16. Specific lobbying issues

HR 6228/S 593 The Ban Poisonous Act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All
provisions and amendments pertaining to the ban and the testing are relevant.)

HR 4341 Bisphenol-A consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)

HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)

S 510 Food Safety Modernization Act, a bill to modernize the Food and Drug Administrations regulation of food safety; (All provisions related to adding an amendment on Bisphenol-A.)

HR 1332 Safe FEAST Act of 2009, a bill to empower the Food and Drug Administration to more thoroughly protect the food supply; (All provisions relating to BPA.)

S 510 Food Safety and Modernization Act; (All sections.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions
and amendments pertaining to the ban and the testing are relevant.)

HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)

HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)

HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.)

HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.)

HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.)

HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.)

HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.)

S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.)

HR 1321 Healthy Americans Act; (Relating to Medicare)

Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.)

HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare.)

HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.)

HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.)

S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CHM

16. Specific lobbying issues

HR 2868 Chemical Facility Anti-Terrorism Act of 2009, a bill to amend the Homeland Security Act of 2009; (all provisions related to the enhancement and protection of chemical facilities against acts of terrorism.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code INS

16. Specific lobbying issues

Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs.)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MAN

16. Specific lobbying issues

HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.)
HR 4394 Decabromine Elimination and Control Act; (Strategy for input into the bill.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

HR 1321 Healthy Americans Act; (Provisions relating to Medicare)
Senate Finance Committee Chairman's Mark, America's healthy Future Act of 2009; (All provisions.)
HR 3962 Affordable health Care for America Act; (Sections relating to health insurance and drugs.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

HR 1427 Promotoing Innovation and Access to Life-Saving Medicne Act; (all relating to follow-on biologics.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code RRR

16. Specific lobbying issues

HR 233 The Railroad Antitrust Enforcement Act of 2009, a bill to amend Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)
S 146 Railroaad Anti-Trust Enforcement Act, a bill to amend the Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)

S 2889 Surface Transportation Reauthorization Act 2009, a bill to reauthorize the Surface Trasportation Act and for other purposes; (All provisions related to bottleneck provisions, common carrier, injunctive relief, rate quotation, competition, and service necessary to business and public interest.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAR

16. Specific lobbying issues

HR 4380- Miscellaneous Tariff Bill, to amend the Harmonized Tariff Schedule and temporarily suspend or modify current rates of tariff; (All provisions related to the tariff bills introduced below):
A bill to extend the temporary suspension of duty on o-Acetylsalicylic acid (Aspirin).
A bill to suspend temporarily the duty on Propoxur (Sedran Technical).
S 2712 A bill to extend the temporary suspension of duty on D-Mannose

S 2169 A bill to extend the suspension of duty on Mixtures of Methyl o-toluenesulonate and methyl p-toluenesulfonate (TSME).

S 2169 A bill to extend the suspension of duty on Trimethylopropane tris(3-aziridinylpropanoate) (Xama 2)

2166 A bill to extend the suspension of duty on Polyfunctional aziridine (Xama 7).

S 2187 A bill to extend the suspension of duty on 1,3-Diisocyanatomethylbenzene, polymer with 1,6-diisocyanatohexane (Desmondur VP HL).

S 2189 A bill to extend the suspension of duty on A linear aromatic polyurethane prepolymer based on toluene diisocyanate. (Desmondur E 14

S 2188 A bill to extend the suspension of duty on Poly(toluene diisocyanate) (Desmondur IL BA).

S 2190 A bill to extend the suspension of duty on Polyisocyanate cross linking agent products containing triphenylmethane triisocyanate in solvents, (Desmondur R-E).

S 2185 A bill to extend suspension of duty on Mixtures of tris(4-isocyanatophenyl)thiophosphate) in solvents, (Desmondur RF-E).

S 2167 A bill to extend the suspension of duty on hexane 1,6, diisocynato-, homopolymer, 3,5, dimethyl-1H-pyrazole-blocked solvents.( Desmodur VP LS 2253)

S2186 A bill to extend the suspension of duty on Copolymer of methyl ethyl ketoximine and toluene diisocyanate (Desmondur BL XP).

S 2165) A bill to extend the suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1-hexanol-blocked (Crelan).

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAR

16. Specific lobbying issues

HR 4380 A bill to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes; (All provisions related to chemicals listed below)
A bill to suspend temporarily the duty on Olympus WG70
A bill to reduce temporarily the duty on Spirotetramat
A bill to suspend temporarily the duty on Flubendiamide

A bill to reduce temporarily the duty on AE 0172747 Ether

A bill to suspend temporarily the duty on 1,3-Cyclohexanedione.

A bill to extend the temporary suspension of duty on Trichloroacetaldehyde (Chloral)

A bill to extend the temporary suspension of duty on p-chlorobenzaldehyde

A bill to suspend temporarily the duty on mixtures containing 5-Cyclospropyl-4-2(2-Methylsulfonyl-4-Trifluoromethylbenoxyl)Isoxazole (BALANCE PRO)

A bill to suspend temporarily the duty on Isoxaflutole

A bill to extend the reduction of duty on product mixtures containing Iprodione: 3-(3-5,dicholorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide and application adjuvants (ROVRAL)

A bill to extend the temporary suspension of duty on 2-Acetylbutyrolactone

A bill to extend the temporary reduction in duty on Beta-cyfluthrin

A bill to extend the temporary suspension of duty on Cyfluthrin

A bill to temporary suspend the general rate of duty on Clothianidin

A bill to extend the temporary suspension of duty on Ethoprop

A bill to extend the temporary suspension of duty on product mixtures containing Foramsulfuron and Iodosulfuronmethyl-sodium (Equip)

A bill to extend the temporary suspension of duty on Isoxadifen-Ethyl

A bill to extend the temporary reduction of duty on Trifloxystrobin

A bill to extend the temporary suspension of duty on Spiromesifen

A bill to suspend temporarily the duty on Thiencarbazone-methyl

A bill to extend the temporary suspension of duty on FOE Hydroxy

A bill to reduce temporarily the duty on product mixtures containing Tembotrione and application adjuvants ( LAUDIS)

A bill to suspend temporarily the duty on products containing (E)-N-[(2-Chloro-1,3-thiazol-5-yl) methyl]-N-methyl[oxido(oxo)hydrazono] methanediamine or N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-{(E)-(methylamino) [oxido(oxo)hydrazono] methyl}amine and application adjucants (PONCHO)

A bill to suspend temporarily the duty on 2(Methylthio)-4-(trifluoromethyl) benzoic acid CAS [142994-05-6]

A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene (CAS [82961-52-2])


A bill to suspend temporarily the duty on products containing 3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-dimethylbutyrate and application adjuvants
(OBERON & FORBID)

A bill to suspend temporarily the duty on mixtures containing Pyrasulfotole: 5-Hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone; and Bromoxynil Octanoate: 2,4-Dibromo-6-cyanophenyl octanoate; and Bromoxynil Heptanoate: 2,4-Dibromo-6-cyanophenyl heptanoate (HUSKIE)

A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one (CAS [5203-77-0], [2749-59-9])

A bill to reduce temporarily the duty on product mixtures containing Thiencarbazone-methyl: Methyl 4-({[(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)carbonyl]amino}sulfonyl)-5-methylthiophene-3-carboxylate and Isoxadifen-ethyl: ethyl 4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylate and Tembotrione: 2-{2-Chloro-4-mesyl-3-[(trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione and application adjuvants (HTSUS 3808.93.15; CAS: 317815-83-1, 163520-33-0, 335104-84-2) (CAPRENO)

A bill to suspend temporarily the duty on Cyprosulfamide: N-({4-[(Cyclopropylamino) carbonyl]phenyl}sulfonyl)-2-methoxybenzamide (CAS No. Cyprosulfamide: 221667-31-8)

A bill to extend the temporary reduction of duty on ACM

A bill to reduce temporarily the duty on Oxadiazon

A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants (AUTUMN)

A bill to extend the temporary suspension of duty on Mesosulfuronmethyl (OSPREY & SILVERADO)

A bill to suspend temporarily the duty on mixtures containing Ethyl(R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop Ethyl), (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrafulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2), and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8) (WOLVERINE)

A bill to suspend temporarily the duty on 1,2,4 Triazole

A bill to suspend temporarily the duty on Fluopicolide

A bill to suspend temporarily the duty on Fenhexamid

A bill to suspend temporarily the duty on BELT & SYNAPSE

A bill to extend the temporary suspension of duty on Phenmedipham

A bill to extend the temporary suspension of duty on Propiconazole

A bill to extend the temporary suspension of duty on PREVICUR

A bill to extend the temporary suspension of duty on 2,4-dichloroaniline

A bill to extend the temporary reduction in duty of Aluminum tris (O-ethylphosphonate) whether or not mixed with application adjuvants (FOSETYL-AL)
A bill to suspend temporarily the duty on 2,2-Dimethylbutanoic acid 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro(4.5)dec-3-en-4-yl ester (Spirodiclofen)

A bill to extend the temporary suspension of duty on Fenamidone

A bill to temporarily suspend the duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester

A bill to suspend temporarily the duty on Pyrasulfotole

A bill to extend the temporary suspension of duty on Pyrimethanil

A bill to reduce temporarily the duty on CORVUS herbicide

A bill to reduce temporarily the duty on EVERGOL

A bill to reduce temporarily the duty on Imidacloprid Pesticides

A bill to suspend temporarily the duty on LIBERTY, RELY and IGNITE herbicides

A bill to reduce the temporarily the duty on Imidacloprid Technical

A bill to extend the temporary suspension of duty on OPTION & REVOLVER Herbicides

A bill to extend the temporary suspension of duty on 2,6-dibromo-4-cyanophenyl octanoate/heptanoate (Bromoxynil Octanoate / Heptanoate)

A bill to suspend temporarily the product mixtures containing Methyl 2-[({[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl}amino)sulfonyl]-4- [(mesylamino)methyl]benzoate (Mesosulfuron-methyl) and Methyl 4-iodo-2-[3-(4-methoxy -6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoate, sodium salt (Iodosulfuron-methyl-sodium), whether or not mixed with application adjuvants (HTSUS 3808.93.15; CAS 208465-21-8 144550-36-7)
(ATLANTIS)

A bill to suspend temporarily the duty on certain mixtures containing [3-[(6-chloro-3-pridinyl)methyl]-2-thiazolidinylidene]cyanamide (CALYPSO)

A bill to extend the temporary suspension of duty on Permethrin

A bill to extend the temporary suspension of duty on 2-Chlorobenzyl chloride (O-Chlorobenzylchloride)

A bill to suspend temporarily the duty on product mixtures containing Imidacloprid: 1-(6-Chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylidene amine Z9: (9Z)-9-Tricosene (MAXFORCE WG10 & GR0.5)

A bill to extend the temporary suspension of duty on Resmethrin

A bill to extend the temporary suspension of duty on N-3[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide (Flutolanil)

A bill to extend the temporary suspension of duty on product mixtures containing 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-yl)carboxamidosulfonylbenzoate; sodium (4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-ylcarbonyl)(2-methoxycarbonylphenylsulfonyl)azanide & methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-a-(methanesulfonamido)-p-toluate (HTSUS 3808.93.15 AND 9902.24.42; CAS 181274-15-7, 208465-21-8) (RIMFIRE & OLYMPUS FLEX)

To suspend temporarily the duty on Tembotrione

A bill to extend the temporary suspension of duty on Deltamethrin

A bill to suspend temporarily the duty on Hydrazine Hydrate Solution

A bill to extend the temporary reduction of duty on Triadimefon (Bayleton
Technical)

A bill to extend the temporary reduction of duty on Ethofumesate in bulk or mixtures.

A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Cyfluthrin:
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclo-propanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE )

A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Beta-Cyfluthrin:
(RS)-a-cyano-4-fluro-3-phenoxybenzyl(1RS,3RS;1RS,3SR)-2-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE 360)

A bill to reduce temporarily the duty on Benzamide, N-[2-[3-chloro-5 (trifluoromethyl) 2-pyridinyl]ethyl]-2-(trifluoromethyl) (FLUOPYRAM) whether or not mixed with application adjuvants (FLUOPYRAM)

A bill to suspend temporarily the duty on 1,3,5-Triazine-2,4-diamine, N-[(1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1-yl]-6-(1-fluoroethyl) (INDAZIFLAM) whether or not mixed with application adjuvants (HTSUS 2933.69.60; CAS 950782-86-2) ) (INDAZIFLAM)

A bill to extend the temporary suspension of duty on Phosphorus Thiochloride (PSCL3)

A bill to extend the temporary suspension of duty on Desmedipham in bulk or mixtures

A bill to extend the temporary suspension of duty on Phenmedipham

Miscellaneous Tarrif Bill: To seek introduction and passage of a bill in the Senate (similar to HR 4380) that would encompass the following bills already introduced in the Senate into a larger package:

S.2691A bill to reduce temporarily the duty on AE 0172747 Ether.

S.1972 A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants.

S.2689 A bill to reduce the temporary suspension of duty on B-Cyfluthrin.

S.1903 A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one.

S.2489 A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene.

S.2252 A bill to extend the temporary suspension of duty on Clothianidin.


S.1902 A bill to reduce temporarily the duty on Corvus herbicide.

S.2686 A bill to extend and modify the temporary reduction of duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester.

S.2257 A bill to extend the temporary suspension of duty on Deltamethrin.

S.1901 A bill to reduce temporarily the duty on Evergol.

S.2684 A bill to extend the temporary suspension of duty on Fenamidone.

S.2069 A bill to extend the temporary suspension of duty on flutolanil.

S.2687 A bill to extend and modify the temporary suspension of duty on Aluminum tris (O-ethylphosphonate).

S.1900 A bill to reduce temporarily the duty on Liberty, Rely, and Ignite herbicides.

S.1971 A bill to extend the suspension of duty on Mesosulfuronmethyl.

S.2253 A bill to extend the temporary suspension of duty on Permethrin.

S.2683 A bill to suspend temporarily the duty on Pyrasulfotole.

S.2262 A bill to extend the temporary suspension of duty on Resmethrin.

S.2690 A bill to reduce and modify the temporary suspension of duty on Iprodione.

S.2688 A bill to extend the temporary suspension of duty on Triadimefon.

S.1970 A bill to suspend temporarily the duty on mixtures containing ethyl (R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop-p-ethyl) (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrasulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2_, and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8) (provided for in subheading 3808.93.15).

S.2109 A bill to reduce temporarily the duty on mixtures of imidacloprid ((1-[(6-Chloro-3-pyridinyl)methly]-N-nitro-2-imidazolidinimine) with cyfluthrin ((R)-cyano-(4-fluoro-3-phenoxyl)phenyl)methyl (1R,3R)-3-(2.,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate) or its beta-cyfluthrin isomer.

S.2110 A bill to reduce temporarily the duty on Fluopyram.

S.2111 A bill to suspend temporarily the duty on Indaziflam.

Miscellaneous Tariff Bill: Bayer CropScience had previously requested several chemicals to be included in the Miscellaneous Tariff Bill that are no longer part of the companys request. Bayer Crop Science has asked that the following bills or chemicals not be included in the Miscellaneous Tariff Bill on the companys behalf.

A bill to suspend temporarily the duty on Thionyl chloride
A bill to suspend the temporary duty suspension on Sodium Methylate Solution
A bill to suspend temporarily the duty on Spiroxamine
A bill to extend the temporary duty suspension on NORTRON SC

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

HR 2438 To amend the Internal Revenue Code of 1986 to provide temporary bonus research credit for energy related research; (all provisions pertaining to inherently safer technology, citizen suits and information disclosure.)
HR 598 American Recovery and Reinvestment Act of 2009, a bill to expand the research and development tax credit for energy research expenses related to fuel cells, battery technology, renewable energy and carbon capture and sequestration; (All provisions
related to research and development.)

Protocol Number HP-1350 US France protocol to Incomve Tax Treaty; (Provisions relating to entire bill.)

S 1631 Customs Reauthorization Act; (Strategy and input on the bill for Senate Finance staff.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENV

16. Specific lobbying issues

HR 4394 Decabromine Elimination and Control Act; (Strategy for input into the bill.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety. Monitoring food safety provisions.)
HR 2400 Strategies to address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

S 515 A bill to amend title 35, US Code to provice for patent reform; (Sect. 4; Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisions related to Post Grant Procedures.)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization